Genprex Receives U.S. FDA Fast Track Designation for REQORSA(TM) Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
Stock Information for Genprex Inc.
Loading
Please wait while we load your information from QuoteMedia.